1,796
Views
17
CrossRef citations to date
0
Altmetric
Clinical Focus: Pulmonary and Respiratory Conditions - Review

Pulmonary complications of influenza infection: a targeted narrative review

, , , &
Pages 299-308 | Received 05 Nov 2018, Accepted 06 Mar 2019, Published online: 20 Mar 2019

References

  • Ramsey CD, Kumar A. Influenza and endemic viral pneumonia. Crit Care Clin. 2013;29(4):1069–1086.
  • Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415–427.
  • Choi SH, Huh JW, Hong SB, et al. Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia. J Clin Virol. 2015;62:41–47.
  • Centers for Disease Control and Prevention. Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States — 2017–2018 influenza season December 18, 2018. Available from: https://www.cdc.gov/flu/about/burden/2017-2018.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fabout%2Fburden%2Festimates.htm.
  • Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–1300.
  • Hermann B, Lehners N, Brodhun M, et al. Influenza virus infections in patients with malignancies – characteristics and outcome of the season 2014/15. A survey conducted by the infectious diseases working party (AGIHO) of the German society of haematology and medical oncology (DGHO). Eur J Clin Microbiol Infect Dis. 2017;36(3):565–573.
  • Zurli V, Gallotta M, Taccone M, et al. Positive contribution of adjuvanted influenza vaccines to the resolution of bacterial superinfections. J Infect Dis. 2016;213(12):1876–1885.
  • Zhou F, Li H, Gu L, et al. Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients. Respir Med. 2018;134:86–91.
  • Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A (H1N1) virus and bacterial co-infection in the United States. Crit Care Med. 2012;40(5):1487–1498.
  • Metersky ML, Masterton RG, Lode H, et al. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza. Int J Infect Dis. 2012;16(5):e321–31.
  • Morland B, Brantsaeter AB, Fuglesang JE, et al. NIPH systematic reviews: executive summaries. Effect of oseltamivir (Tamiflu(R)) for the prevention and treatment of influenza during an influenza pandemic. Oslo (Norway): Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH Copyright (c)2005 by The Norwegian Institute of Public Health (NIPH); 2005.
  • Lehnert R, Pletz M, Reuss A, et al. Antiviral medications in seasonal and pandemic influenza. Dtsch Arztebl Int. 2016;113(47):799–807.
  • Louria DB, Blumenfeld HL, Ellis JT, et al. Studies on influenza in the pandemic of 1957-1958. II. pulmonary complications of influenza. J Clin Investig. 1959;38(1Pt 1–2):213–265.
  • Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet. 1958;2(7057):1141–1143.
  • Rodriguez A, Martin-Loeches I, Bonastre J, et al. First influenza season after the 2009 pandemic influenza: report of the first 300 ICU admissions in Spain. Med Intensiva. 2011;35(4):208–216.
  • Estenssoro E, Ríos FG, Apezteguía C, et al. Pandemic 2009 Influenza A in Argentina. Am J Respir Crit Care Med. 2010;182(1):41–48.
  • Fujikura Y, Kawano S, Kouzaki Y, et al. The (H1N1) 2009 pandemic influenza pneumonia among adult patients in Japan. Jpn J Infect Dis. 2014;67(2):100–104.
  • Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139(3):555–562.
  • Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. New Engl J Med. 2009;361(7):680–689.
  • Rodríguez A, Socías L, Guerrero JE, et al. Gripe A pandémica en una unidad de cuidados intensivos: experiencia en España y Latinoamérica (Grupo Español de Trabajo de Gripe A Grave/Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias). Med Intensiva. 2010;34(2):87–94.
  • Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza a(h1n1) infection in canada. JAMA. 2009;302(17):1872–1879.
  • Investigators TAI. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925–1934.
  • Rello J, Rodríguez A, Ibañez P, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care. 2009;13(5):R148.
  • Gutierrez-Pizarraya A, Perez-Romero P, Alvarez R, et al. Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. J Infect. 2012;65(5):423–430.
  • Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309(3):275–282.
  • Rodríguez AH, Avilés-Jurado FX, Díaz E, et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect. 2016;72(2):143–151.
  • Martin-Loeches I, van Someren Greve F, Schultz MJ. Bacterial pneumonia as an influenza complication. Curr Opin Infect Dis. 2017;30(2):201–207.
  • Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med. 2011;37(5):796–800.
  • Song JY, Cheong HJ, Heo JY, et al. Clinical, laboratory and radiologic characteristics of 2009 pandemic influenza A/H1N1 pneumonia: primary influenza pneumonia versus concomitant/secondary bacterial pneumonia. Influenza Other Respir Viruses. 2011;5(6):e535–43.
  • Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis. 2019;68:895–902.
  • Hayashi Y, Vaska VL, Baba H, et al. Influenza-associated bacterial pathogens in patients with 2009 influenza A (H1N1) infection: impact of community-associated methicillin-resistant staphylococcus aureus in Queensland, Australia. Intern Med J. 2012;42(7):755–760.
  • Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis. 2016;3(3):ofw171.
  • van de Veerdonk FL, Kolwijck E, Lestrade PP, et al. Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2017.
  • Alshabani K, Haq A, Miyakawa R, et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Rev Respir Med. 2015;9(1):89–96.
  • Burke J, Soubani AO. Influenza and Pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplantation recipient: coinfection or superinfection? Transplant Infect Dis. 2018;20:1.
  • van Kampen JJ, Bielefeld-Buss AJ, Ott A, et al. Case report: oseltamivir-induced resistant pandemic influenza A (H1N1) virus infection in a patient with AIDS and pneumocystis jirovecii pneumonia. J Med Virol. 2013;85(6):941–943.
  • Asai N, Yokoi T, Nishiyama N, et al. Secondary organizing pneumonia following viral pneumonia caused by severe influenza B: a case report and literature reviews. BMC Infect Dis. 2017;17(1):572.
  • Cornejo R, Llanos O, Fernandez C, et al. Organizing pneumonia in patients with severe respiratory failure due to novel A (H1N1) influenza. BMJ case reports. 2010;2010:2078.
  • Hosseini SS, Ghasemian E, Jamaati H, et al. Association between respiratory viruses and exacerbation of COPD: a case-control study. Infect Dis (Lond). 2015;47(8):523–529.
  • Mallia P, Contoli M, Caramori G, et al. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. Curr Pharm Des. 2007;13(1):73–97.
  • Wedzicha JA. Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(2):115–120.
  • Zwaans WA, Mallia P, van Winden ME, et al. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease-a systematic review. J Clin Virol. 2014;61(2):181–188.
  • Varkey JB, Varkey B. Viral infections in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2008;14(2):89–94.
  • Bekkat-Berkani R, Wilkinson T, Buchy P, et al. Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulm Med. 2017;17(1):79.
  • Garrastazu R, Garcia-Rivero JL, Ruiz M, et al. Prevalence of influenza vaccination in chronic obstructive pulmonary disease patients and impact on the risk of severe exacerbations. Arch Bronconeumol. 2016;52(2):88–95.
  • Lall D, Cason E, Pasquel FJ, et al. Effectiveness of influenza vaccination for individuals with chronic obstructive pulmonary disease (COPD) in low- and middle-income countries. Copd. 2016;13(1):93–99.
  • Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681–689.
  • Ortiz JR, Neuzil KM, Victor JC, et al. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest. 2010;137(4):852–860.
  • Wat D, Gelder C, Hibbitts S, et al. Is there a role for influenza vaccination in cystic fibrosis? J Cyst Fibros. 2008;7(1):85–88.
  • Renk H, Regamey N, Hartl D. Influenza A(H1N1)pdm09 and cystic fibrosis lung disease: a systematic meta-analysis. PLoS One. 2014;9(1):e78583.
  • Short KR, Kroeze E, Fouchier RAM, et al. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014;14(1):57–69.
  • Bonmarin I, Belchior E, Bergounioux J, et al. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons. Eurosurveillance. 2015;20(46):30066.
  • Topfer L, Menk M, Weber-Carstens S, et al. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course. J Crit Care. 2014;29(3):340–346.
  • Buchner J, Mazzeffi M, Kon Z, et al. Single-center experience with venovenous ECMO for influenza-related ARDS. J Cardiothorac Vasc Anesth. 2018;32:1154–1159.
  • Töpfer L, Menk M, Weber-Carstens S, et al. Influenza A (H1N1) vs non-H1N1 ARDS: analysis of clinical course. J Crit Care. 2014;29(3):340–346.
  • Ukimura A, Satomi H, Ooi Y, et al. Myocarditis associated with influenza A H1N1pdm2009. Influenza Res Treat. 2012;2012:351979.
  • Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortalityseasonal influenza infections and cardiovascular disease mortalityseasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281.
  • Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol. 2013;167(6):2397–2403.
  • Madjid M, Naghavi M, Litovsky S, et al. Influenza and cardiovascular disease. Circulation. 2003;108(22):2730–2736.
  • Campbell LA, Rosenfeld ME. Infection and atherosclerosis development. Arch Med Res. 2015;46(5):339–350.
  • Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom general practice research database. Am J Epidemiol. 2008;169(3):382–388.
  • Vellozzi C, Broder K, Iqbal S. Guillain-Barré syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clinl Infect Dis. 2014;58(8):1149–1155.
  • Vos R, Verleden SE, Verleden GM. Chronic lung allograft dysfunction: evolving practice. Curr Opin Organ Transplant. 2015;20(5):483–491.
  • Ng BJ, Glanville AR, Snell G, et al. The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients. Am J Transplant. 2011;11(3):568–574.
  • Creanga AA, Berg CJ, Syverson C, et al. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015;125(1):5–12.
  • Mertz D, Geraci J, Winkup J, et al. Pregnancy as a risk factor for severe outcomes from influenza virus infection: a systematic review and meta-analysis of observational studies. Vaccine. 2017;35(4):521–528.
  • Sokolow LZ, Naleway AL, Li D-K, et al. Severity of influenza and noninfluenza acute respiratory illness among pregnant women, 2010–2012. Am J Clin Exp Obstet Gynecol. 2015;212(2):202.e1-.e11.
  • Centers for Disease Control and Prevention. Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)–United States, April 2009-August 2010. MMWR Morb Mortal Wkly Rep. 2011;60(35):1193–1196.
  • Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond). 2017;41(9):1324–1330.
  • Maier HE, Ng S, Gordon A, et al. Obesity increases the duration of influenza A virus shedding in adults. J Infect Dis. 2018;218(9):1378–1382.
  • Fezeu L, Julia C, Henegar A, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obesity Rev. 2011;12(8):653–659.
  • Segaloff HE, Evans R, Arshad S, et al. The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults. J Med Virol. 2018;90(2):212–218.
  • Ruuskanen O, Peltola V, Ziegler T. Influenza A and B virus infections in children. Clinl Infect Dis. 2003;36(3):299–305.
  • Seok HY, Shin HY, Kim JK, et al. The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis. J Clin Neurol. 2017;13(4):325–330.
  • Umeda Y, Morikawa M, Anzai M, et al. Acute exacerbation of idiopathic pulmonary fibrosis after pandemic influenza A (H1N1) vaccination. Intern Med. 2010;49(21):2333–2336.
  • Larranaga JM, Marcos PJ, Pombo F, et al. Acute eosinophilic pneumonia as a complication of influenza A (H1N1) pulmonary infection. Sarcoidosis, Vasculitis, Diffuse Lung Dis. 2016;33(1):95–97.
  • von Ranke FM, Zanetti G, Hochhegger B, et al. Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review. Lung. 2013;191(1):9–18.
  • Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935–1944.
  • Paddock CD, Liu L, Denison AM, et al. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis. 2012;205(6):895–905.
  • Nolan TF, Goodman RA, Hinman AR, et al. Morbidity and mortality associated with influenza B in the United States, 1979-1980. a report from the center for disease control. J Infect Dis. 1980;142(3):360–362.
  • Liou YS, Barbour SD, Bell LM, et al. Children hospitalized with influenza B infection. Pediatr Infect Dis J. 1987;6(6):541–543.
  • Hite LK, Glezen WP, Demmler GJ, et al. Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis. 2007;11(1):40–47.
  • Kim YH, Kim HS, Cho SH, et al. Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunol. 2009;22(6):423–430.
  • Kim HW, Brandt CD, Arrobio JO, et al. Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol. 1979;109(4):464–479.
  • Aebi T, Weisser M, Bucher E, et al. Co-infection of Influenza B and Streptococci causing severe pneumonia and septic shock in healthy women. BMC Infect Dis. 2010;10:308.
  • Rein JL, Etra AM, Patel JJ, et al. Death of woman with peripartum influenza B virus infection and necrotizing pneumonia. Emerg Infect Dis. 2014;20(7):1258–1260.
  • Roberts JC, Gulino SP, Peak KK, et al. Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive staphylococcus aureus and influenza co-infection: a case report. Ann Clin Microbiol Antimicrob. 2008;7:5.
  • Simmerman JM, Chittaganpitch M, Levy J, et al. Incidence, seasonality and mortality associated with influenza pneumonia in thailand: 2005–2008. PLOS ONE. 2009;4(11):e7776.
  • Irving SA, Patel DC, Kieke BA, et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008. Influenza Other Respir Viruses. 2012;6(1):37–43.
  • Wie SH, So BH, Song JY, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: a multi-center study. PLoS One. 2013;8(5):e62685.
  • Hong KW, Cheong HJ, Song JY, et al. Clinical manifestations of influenza A and B in children and adults at a tertiary hospital in Korea during the 2011-2012 season. Jpn J Infect Dis. 2015;68(1):20–26.
  • Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis. 2003;36(3):299–305.
  • Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta‐analysis. Influenza Other Respir Viruses. 2016;10(5):394–403.
  • Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53(3):358–365.
  • Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Bmj. 1995;310(6989):1225–1229.
  • Schwarze J, Openshaw P, Jha A, et al. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI influenza in asthma task force. Allergy. 2018;73:1151–1181.
  • Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58(1):37–42.
  • Koul PA, Khan UH, Asad R, et al. Contribution of influenza to acute exacerbations of chronic obstructive pulmonary disease in Kashmir, India, 2010–2012. Influenza Other Respir Viruses. 2015;9(1):40–42.
  • Dawood FS, Kamimoto L, D’Mello TA, et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics. 2011;128(1):e27–32.
  • Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123(7):518–527.
  • Nichol KL, Baken L, Nelson A. RElation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130(5):397–403.
  • Puig-Barberà J, Marquez-Calderon S, Masoliver-Fores A, et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health. 1997;51(5):526–530.
  • Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine. 1999;17(Suppl 1):S91–3.
  • Boikos C, Caya C, Doll MK, et al. Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15. J Antimicrob Chemother. 2017;72(6):1556–1573.
  • Williamson JC, Pegram PS. Respiratory distress associated with zanamivir. N Engl J Med. 2000;342:661–662.
  • Eagel BA. The truth about Tamiflu? Zanamivir should be inhaled, not nebulised. BMJ (Clin Res Ed). 2010;340:c131–c.
  • Carter MJ. A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J Med Microbiol. 2007;56(Pt 7):875–883.
  • Yang JW, Fan LC, Miao XY, et al. Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21(10):956–963.
  • Brun-Buisson C, Richard JC, Mercat A, et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011;183(9):1200–1206.
  • Nedel WL, Nora DG, Salluh JI, et al. Corticosteroids for severe influenza pneumonia: a critical appraisal. World J Crit Care Med. 2016;5(1):89–95.
  • Cao B, Gao H, Zhou B, et al. Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia. Crit Care Med. 2016;44(6):e318–28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.